Skip to main content

Advertisement

SpringerLink
Log in

Hidradenitis suppurativa/​Acne inversa

Ein Update

Hidradenitis suppurativa/​acne inversa

An update

  • Übersichten
  • Published:
coloproctology Aims and scope

Zusammenfassung

Hidradenitis suppurativa/Acne inversa (HS/AI) ist eine chronische, inflammatorische Hauterkrankung, die sich durch schmerzhafte Knoten, Abszesse, Fisteln und Vernarbungen auszeichnet und zu deutlichen funktionellen sowie psychologischen Beeinträchtigungen bei den betroffenen Patienten führen kann. Es vergehen oft Jahre, bis die richtige Diagnose gestellt wird. Die Behandlung der HS/AI stellt weiterhin eine Herausforderung dar. Konservative Therapien können in initialen Stadien der Erkrankung zu einer Besserung, nicht aber Heilung der Erkrankung führen. Bei fortgeschrittenen Stadien bleibt die radikale Exzision weiterhin die Therapie der Wahl.

Abstract

Hidradenitis suppurativa/acne inversa (HS/AI) is a chronic inflammatory disease characterized by painful nodules, abscesses, fistulas, sinus tracts and scarring, which may lead to severe functional and psychological impairment. Patients often suffer for many years before the right diagnosis is finally made. HS/AI is still a therapeutic challenge. Conservative therapies play a role in mild stages of the disease; however they do not result in healing. Therapy of choice associated with the lowest recurrence rate is a radical wide excision of involved skin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Adams DR, Yankura JA, Fogelberg AC et al (2010) Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol 146:501–504

    CAS  PubMed  Google Scholar 

  2. Al-Ali FMS, Ratnamala U, Mehta TY et al (2010) Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1–1q25.3 region. Exp Dermatol 19:851–853

    Article  CAS  PubMed  Google Scholar 

  3. Alikhan A, Lynch PJ, Eisen DB (2009) Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 60:539–561. (quiz 562–533)

  4. Amano M, Grant A, Kerdel FA (2010) A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa. Int J Dermatol 49:950–955

    Article  CAS  PubMed  Google Scholar 

  5. Arenbergerova M, Gkalpakiotis S, Arenberger P (2010) Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy. Int J Dermatol 49:1445–1449

    Article  PubMed  Google Scholar 

  6. Barth JH, Layton AM, Cunliffe WJ (1996) Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 134:1057–1059

    Article  CAS  PubMed  Google Scholar 

  7. Bechara FG, Hartschuh W (2010) Acne inversa. Hautarzt 61:39–46

    Article  CAS  PubMed  Google Scholar 

  8. Bechara FG, Sand M, Skrygan M et al (2012) Acne inversa: evaluating antimicrobial peptides and proteins. Ann Dermatol 24:393–397

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bendahan J, Paran H, Kolman S et al (1992) The possible role of Chlamydia trachomatis in perineal suppurative hidradenitis. Eur J Surg 158:213–215

    CAS  PubMed  Google Scholar 

  10. Blok JL, Van Hattem S, Jonkman MF et al (2013) Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol 168:243–252

    Article  CAS  PubMed  Google Scholar 

  11. Boer J, Nazary M (2011) Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol 164:170–175

    Article  CAS  PubMed  Google Scholar 

  12. Brocard A, Knol A-C, Khammari A et al (2007) Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology 214:325–327

    Article  CAS  PubMed  Google Scholar 

  13. Canoui-Poitrine F, Revuz JE, Wolkenstein P et al (2009) Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 61:51–57

    Article  PubMed  Google Scholar 

  14. Chen YE, Gerstle T, Verma K et al (2014) Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device. Plast Reconstr Surg 133:370e-377e

    Article  CAS  PubMed  Google Scholar 

  15. Constantinou C, Widom K, Desantis J et al (2008) Hidradenitis suppurativa complicated by squamous cell carcinoma. Am Surg 74:1177–1181

    PubMed  Google Scholar 

  16. Cosmatos I, Matcho A, Weinstein R et al (2013) Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol 68:412–419

    Article  PubMed  Google Scholar 

  17. Danby FW, Jemec GBE, Marsch WC et al (2013) Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. Br J Dermatol 168:1034–1039

    Article  CAS  PubMed  Google Scholar 

  18. Deckers IE, Van Der Zee HH, Boer J et al (2015) Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol 72:485–488

    Article  PubMed  Google Scholar 

  19. Downs A (2004) Smoothbeam laser treatment may help improve hidradenitis suppurativa but not Hailey-Hailey disease. J Cosmet Laser Ther 6:163–164

    Article  PubMed  Google Scholar 

  20. Dreno B, Khammari A, Brocard A et al (2012) Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol 148:182–186

    Article  CAS  PubMed  Google Scholar 

  21. Durmaz R, Tekerekoǧlu MS, Kalcioǧlu T et al (2001) Nasal carriage of methicillin-resistant Staphylococcus aureus among smokers and cigarette factory workers. New Microbiol 24:143–147

    CAS  PubMed  Google Scholar 

  22. Emelianov VU, Bechara FG, Gläser R et al (2012) Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Br J Dermatol 166:1023–1034

    Article  CAS  PubMed  Google Scholar 

  23. Estrach S, Cordes R, Hozumi K et al (2008) Role of the Notch ligand Delta1 in embryonic and adult mouse epidermis. J Invest Dermatol 128:825–832

    Article  CAS  PubMed  Google Scholar 

  24. Fain JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74:443–477

    Article  CAS  PubMed  Google Scholar 

  25. Fitzsimmons JS, Guilbert PR, Fitzsimmons EM (1985) Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol 113:1–8

    Article  CAS  PubMed  Google Scholar 

  26. Gao M, Wang P-G, Cui Y et al (2006) Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1–1q25.3. J Invest Dermatol 126:1302–1306

    Article  CAS  PubMed  Google Scholar 

  27. Gener G, Canoui-Poitrine F, Revuz JE et al (2009) Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 219:148–154

    Article  CAS  PubMed  Google Scholar 

  28. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C et al (2007) Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 156:51–56

    Article  CAS  PubMed  Google Scholar 

  29. Girouard SD, Falk RH, Rennke HG et al (2012) Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J 18:2

    PubMed  Google Scholar 

  30. Grant A, Gonzalez T, Montgomery MO et al (2010) Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol 62:205–217

    Article  CAS  PubMed  Google Scholar 

  31. Gulliver WP, Jemec GBE, Baker KA (2012) Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa. J Eur Acad Dermatol Venereol 26:911–914

    Article  CAS  PubMed  Google Scholar 

  32. Hana A, Booken D, Henrich C et al (2007) Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci 80:2214–2220

    Article  CAS  PubMed  Google Scholar 

  33. Harrison BJ, Mudge M, Hughes LE (1987) Recurrence after surgical treatment of hidradenitis suppurativa. Br Med J (Clin Res Ed) 294:487–489

    Article  CAS  Google Scholar 

  34. Hazen PG, Hazen BP (2010) Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg 36:208–213

    Article  CAS  PubMed  Google Scholar 

  35. Hessam S, Sand M, Georgas D et al (2013) Laserepilation bei Hidradenitis suppurativa/Acne inversa und Pilonidalsinus. Aktuelle Derm 39:268–277

    Article  Google Scholar 

  36. Highton L, Chan W-Y, Khwaja N et al (2011) Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study. Plast Reconstr Surg 128:459–465

    Article  CAS  PubMed  Google Scholar 

  37. Humira Fachinformation, Stand: Juli 2015. http://www.fachinfo.de/pdf/010078

  38. Hurley H (1996) Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk R, Roenigk H (Hrsg) Roenigk & Roenigk’s dermatologic surgery: principles and practice, 2. Aufl. Marcel Dekker, New york, S 623–664

  39. Jahns AC, Killasli H, Nosek D et al (2014) Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. APMIS 122:804–809

    Article  PubMed  Google Scholar 

  40. Jain V, Jain A (2012) Use of lasers for the management of refractory cases of hidradenitis suppurativa and pilonidal sinus. J Cutan Aesthet Surg 5:190–192

    Article  PubMed  PubMed Central  Google Scholar 

  41. Jemec GB (2003) Hidradenitis suppurativa. J Cutan Med Surg 7:47–56

    Article  PubMed  Google Scholar 

  42. Jemec GBE (2012) Clinical practice. Hidradenitis suppurativa. N Engl J Med 366:158–164

    Article  CAS  PubMed  Google Scholar 

  43. Jemec GB, Gottlieb A, Forman S (2014) Efficacy and Safety of Adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from PIONEER II, a Phase 3, randomized, placebo-controlled trial. In: 23rd congress of the EADV, Amsterdam 2014. Abstract FC08.2

  44. Jemec GB, Gniadecka M (1997) Sebum excretion in hidradenitis suppurativa. Dermatology 194:325–328

    Article  CAS  PubMed  Google Scholar 

  45. Jemec GB, Wendelboe P (1998) Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39:971–974

    Article  CAS  PubMed  Google Scholar 

  46. Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 35:191–194

    Article  CAS  PubMed  Google Scholar 

  47. Jemec GB, Gottlieb A, Forman S et al (2014) Efficacy and Safety of Adalimumab in Patients with Moderate to Severe Hidradenitis Suppurativa: Results from PIONEER II, a Phase 3, Randomized, Placebo-Controlled Trial. Abstract FC08.2. 23rd Congress of the European Dermatology and Venereology (EADV) Meeting, Amsterdam, Netherlands 2014

  48. Jeong SH, Park JH, Kim JN et al (2010) Up-regulation of TNF-alpha secretion by cigarette smoke is mediated by Egr-1 in HaCaT human keratinocytes. Exp Dermatol 19:e206–212

    Article  PubMed  Google Scholar 

  49. Join-Lambert O, Coignard H, Jais J-P et al (2011) Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology 222:49–58

    Article  CAS  PubMed  Google Scholar 

  50. Joseph MA, Jayaseelan E, Ganapathi B et al (2005) Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat 16:75–78

    Article  CAS  PubMed  Google Scholar 

  51. Kathju S, Lasko LA, Stoodley P (2012) Considering hidradenitis suppurativa as a bacterial biofilm disease. FEMS Immunol Med Microbiol 65:385–389

    Article  CAS  PubMed  Google Scholar 

  52. Kimball AB, Kerdel F, Adams D et al (2012) Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med 157:846–855

    Article  PubMed  Google Scholar 

  53. Kimball A, Zouboulis CC, Armstrong AW et al (2014) Safety and Efficacy of Adalimumab in Patients with Moderate to Severe Hidradenitis Suppurativa: Results from First 12 Weeks of PIONEER I, a Phase 3, Randomized, Placebo-Controlled Trial. Abstract #210. 44th Annual Meeting of the European Society for Dermatological Research (ESDR), Copenhagen, Denmark. http://www.nature.com/jid/journal/v134/n2s/full/jid2014340a.html

  54. Kintz P, Henrich A, Cirimele V et al (1998) Nicotine monitoring in sweat with a sweat patch. J Chromatogr B Biomed Sci Appl 705:357–361

    Article  CAS  PubMed  Google Scholar 

  55. Konety BR, Cooper T, Flood HD et al (1996) Scrotal elephantiasis associated with hidradenitis suppurativa. Plast Reconstr Surg 97:1243–1245

    Article  CAS  PubMed  Google Scholar 

  56. König A, Lehmann C, Rompel R et al (1999) Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 198:261–264

    Article  PubMed  Google Scholar 

  57. Kraft JN, Searles GE (2007) Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg 11:125–131

    Article  CAS  PubMed  Google Scholar 

  58. Kurek A, Johanne Peters EM, Sabat R et al (2013) Depression is a frequent co-morbidity in patients with acne inversa. J Dtsch Dermatol Ges 11:743–749, 743–750

    PubMed  Google Scholar 

  59. Kurzen H, Wessler I, Kirkpatrick CJ et al (2007) The non-neuronal cholinergic system of human skin. Horm Metab Res 39:125–135

    Article  CAS  PubMed  Google Scholar 

  60. Kurzen H, Kurokawa I, Jemec GBE et al (2008) What causes hidradenitis suppurativa? Exp Dermatol 17:455–456 (discussion 457–472)

    Article  CAS  PubMed  Google Scholar 

  61. Lapins J, Jarstrand C, Emtestam L (1999) Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 140:90–95

    Article  CAS  PubMed  Google Scholar 

  62. Lefort K, Mandinova A, Ostano P et al (2007) Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinases. Genes Dev 21:562–577

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Leslie KS, Tripathi SV, Nguyen TV et al (2014) An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. J Am Acad Dermatol 70:243–251

    Article  CAS  PubMed  Google Scholar 

  64. Li T, Wen H, Brayton C et al (2007) Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase. J Biol Chem 282:32264–32273

    Article  CAS  PubMed  Google Scholar 

  65. Lowell S, Jones P, Le Roux I et al (2000) Stimulation of human epidermal differentiation by Delta-Notch signalling at the boundaries of stem-cell clusters. Curr Biol 10:491–500

    Article  CAS  PubMed  Google Scholar 

  66. Lunniss PJ, Jenkins PJ, Besser GM et al (1995) Gender differences in incidence of idiopathic fistula-in-ano are not explained by circulating sex hormones. Int J Colorectal Dis 10:25–28

    Article  CAS  PubMed  Google Scholar 

  67. Maclean GM, Coleman DJ (2007) Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 89:709–712

    Article  PubMed  PubMed Central  Google Scholar 

  68. Martin-Ezquerra G, Masferrer E, Masferrer-Niubò M et al (2015) Use of biological treatments in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 29:56–60

    Article  CAS  PubMed  Google Scholar 

  69. Matusiak L, Bieniek A, Szepietowski JC (2009) Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents? Acta Derm Venereol 89:601–603

    Article  CAS  PubMed  Google Scholar 

  70. Matusiak L, Bieniek A, Szepietowski JC (2014) Bacteriology of Hidradenitis suppurativa – which antibiotics are the treatment of choice? Acta Derm Venereol 94:699–702

    Article  PubMed  Google Scholar 

  71. Melnik BC, Plewig G (2013) Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa). Br J Dermatol 168:876–878

    Article  CAS  PubMed  Google Scholar 

  72. Mendonça CO, Griffiths CEM (2006) Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 154:977–978

    Article  PubMed  CAS  Google Scholar 

  73. Miller I, Lynggaard CD, Lophaven S et al (2011) A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol 165:391–398

    Article  CAS  PubMed  Google Scholar 

  74. Mortaz E, Adcock IM, Ito K et al (2010) Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor. Eur Respir J 36:1143–1154

    Article  CAS  PubMed  Google Scholar 

  75. Mortimer PS, Lunniss PJ (2000) Hidradenitis suppurativa. J R Soc Med 93:420–422

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Mortimer PS, Dawber RP, Gales MA et al (1986) A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 115:263–268

    Article  CAS  PubMed  Google Scholar 

  77. Mühlstädt M, Bechara FG, Kunte C (2013) Acne inversa (hidradenitis suppurativa). Erkennen – Verstehen – Therapieren. Hautarzt 64:55–61 (quiz 62)

    Article  PubMed  Google Scholar 

  78. Ogawa R (2010) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 125:557–568

    Article  CAS  PubMed  Google Scholar 

  79. Ouchi N, Parker JL, Lugus JJ et al (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Pan Y, Lin MH, Tian X et al (2004) gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev Cell 7:731–743

    Article  CAS  PubMed  Google Scholar 

  81. Paradela S, Rodriguez-Lojo R, Fernandez-Torres R et al (2012) Long-term efficacy of infliximab in hidradenitis suppurativa. J Dermatolog Treat 23:278–283

    Article  CAS  PubMed  Google Scholar 

  82. Pavia CS, Pierre A, Nowakowski J (2000) Antimicrobial activity of nicotine against a spectrum of bacterial and fungal pathogens. J Med Microbiol 49:675–676

    Article  CAS  PubMed  Google Scholar 

  83. Pink AE, Simpson MA, Desai N et al (2012) Mutations in the γ-Secretase Genes NCSTN, PSENEN, and PSEN1 Underlie Rare Forms of Hidradenitis Suppurativa (Acne Inversa). J Invest Dermatol 132:2459–2461

    Article  CAS  PubMed  Google Scholar 

  84. Pink AE, Simpson MA, Desai N et al (2013) γ-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis. J Invest Dermatol 133:601–607

    Article  CAS  PubMed  Google Scholar 

  85. Plewig G, Steger M (1989) Acne inversa (alias acne triad, acne tetrad or hidradenitis suppurativa). In: Marks R, Plewig G (Hrsg) Acne and related disorders. Martin Dunitz, London, S 345–357

  86. Poli F, Wolkenstein P, Revuz J (2010) Back and face involvement in hidradenitis suppurativa. Dermatology 221:137–141

    Article  PubMed  Google Scholar 

  87. Prasad AS (2008) Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 43:370–377

    Article  CAS  PubMed  Google Scholar 

  88. Proweller A, Tu L, Lepore JJ et al (2006) Impaired notch signaling promotes De novo squamous cell carcinoma formation. Cancer Res 66:7438–7444

    Article  CAS  PubMed  Google Scholar 

  89. Rambhatla PV, Lim HW, Hamzavi I (2012) A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol 148:439–446

    Article  CAS  PubMed  Google Scholar 

  90. Revuz J (2009) Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 23:985–998

    Article  CAS  PubMed  Google Scholar 

  91. Revuz JE, Canoui-Poitrine F, Wolkenstein P et al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59:596–601

    Article  PubMed  Google Scholar 

  92. Sabat R, Chanwangpong A, Schneider-Burrus S et al (2012) Increased prevalence of metabolic syndrome in patients with Acne inversa. PLoS ONE 7:e31810

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Sartorius K, Lapins J, Emtestam L et al (2003) Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149:211–213

    Article  CAS  PubMed  Google Scholar 

  94. Sartorius K, Emtestam L, Jemec GBE et al (2009) Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 161:831–839

    Article  CAS  PubMed  Google Scholar 

  95. Sawers RS, Randall VA, Ebling FJ (1986) Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy. Br J Dermatol 115:269–274

    Article  CAS  PubMed  Google Scholar 

  96. Scheinfeld N (2014) Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2014 Mar 17;20(3). pii: doj_21764

  97. Scheinfeld N (2014) A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma. Dermatol Online J 20

  98. Schlapbach C, Hänni T, Yawalkar N et al (2011) Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 65:790–798

    Article  CAS  PubMed  Google Scholar 

  99. Sehgal VN, Verma P, Sawant S et al (2011) Contemporary surgical treatment of hidradenitis suppurativa (HS) with a focus on the use of the diode hair laser in a case. J Cosmet Laser Ther 13:180–190

    Article  PubMed  Google Scholar 

  100. Sharon VR, Garcia MS, Bagheri S et al (2012) Management of recalcitrant hidradenitis suppurativa with ustekinumab. Acta Derm Venereol 92:320–321

    Article  CAS  PubMed  Google Scholar 

  101. Shavit E, Dreiher J, Freud T et al (2015) Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 29:371–376

    Article  CAS  PubMed  Google Scholar 

  102. Slade DEM, Powell BW, Mortimer PS (2003) Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 56:451–461

    Article  CAS  PubMed  Google Scholar 

  103. Sotiriou E, Goussi C, Lallas A et al (2012) A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa. J Drugs Dermatol 11:s15–20

    CAS  PubMed  Google Scholar 

  104. Tierney E, Mahmoud BH, Hexsel C et al (2009) Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg 35:1188–1198

    Article  CAS  PubMed  Google Scholar 

  105. Torii K, Saito C, Furuhashi T et al (2011) Tobacco smoke is related to Th17 generation with clinical implications for psoriasis patients. Exp Dermatol 20:371–373

    Article  CAS  PubMed  Google Scholar 

  106. Ulrich A, Hildebrandt U, Ulrich J (2014) Acne inversa: Einfluss assoziierter Faktoren auf den Schweregrad und das operative Ergebnis. Hautarzt 65:623–627

    Article  CAS  PubMed  Google Scholar 

  107. Van Der Zee HH, Prens EP (2013) Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case report. Dermatology 226:97–100

    Article  PubMed  Google Scholar 

  108. Van Der Zee HH, Boer J, Prens EP et al (2009) The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 219:143–147

    Article  PubMed  CAS  Google Scholar 

  109. Van Der Zee HH, Prens EP, Boer J (2010) Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 63:475–480

    Article  PubMed  Google Scholar 

  110. Van Der Zee HH, De Ruiter L, Van Den Broecke DG et al (2011) Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1ß and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1ß. Br J Dermatol 164:1292–1298

    Article  PubMed  CAS  Google Scholar 

  111. Van Rappard DC, Leenarts MF, Meijerink-Van ’T, Oost L et al (2012) Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa. J Dermatolog Treat 23:284–289

    Article  PubMed  CAS  Google Scholar 

  112. Vazquez BG, Alikhan A, Weaver AL et al (2013) Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 133:97–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Verdolini R, Clayton N, Smith A et al (2013) Metformin for the treatment of Hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol 27:1101–1108

  114. Von Der Werth JM, Williams HC (2000) The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 14:389–392

    Article  PubMed  Google Scholar 

  115. Wang B, Yang W, Wen W et al (2010) Gamma-secretase gene mutations in familial acne inversa. Science 330:1065

    Article  CAS  PubMed  Google Scholar 

  116. Watt FM, Estrach S, Ambler CA (2008) Epidermal Notch signalling: differentiation, cancer and adhesion. Curr Opin Cell Biol 20:171–179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Williams ST, Busby RC, Demuth RJ et al (1991) Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg 26:456–462

    Article  CAS  PubMed  Google Scholar 

  118. Wolkenstein P, Loundou A, Barrau K et al (2007) Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 56:621–623

    Article  PubMed  Google Scholar 

  119. Young L, Czarnecki D (2012) The rapid onset of multiple squamous cell carcinomas in two patients commenced on ustekinumab as treatment of psoriasis. Australas J Dermatol 53:57–60

    Article  PubMed  Google Scholar 

  120. Yu CC, Cook MG (1990) Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 122:763–769

    Article  CAS  PubMed  Google Scholar 

  121. Zarchi K, Dufour DN, Jemec GBE (2013) Successful treatment of severe hidradenitis suppurativa with anakinra. JAMA Dermatol 149:1192–1194

    Article  PubMed  Google Scholar 

  122. Zitelli KB, Zedek D, Ranganathan P et al (2013) Squamous cell carcinoma of the lip associated with adalimumab therapy for ankylosing spondylitis: a case report and review of TNF-alpha inhibitors and cutaneous carcinoma risk. Cutis 92:35–39

    PubMed  Google Scholar 

  123. Zouboulis CC, Bechara FG, Fritz K et al (2012) S1– Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa. J Dtsch Dermatol Ges 10(Suppl 5):S1–S31

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie, Venerologie und Allergologie, HELIOS St. Elisabeth Klinik Oberhausen, Oberhausen, Deutschland

    J. Kirschke

  2. Klinik für Dermatologie, Venerologie und Allergologie, Abteilung für Dermatochirurgie, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland

    S. Hessam &  F. G. Bechara

Authors
  1. J. Kirschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Hessam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. G. Bechara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. G. Bechara.

Ethics declarations

Interessenkonflikt

J. Kirschke und S. Hessam geben an, dass kein Interessenkonflikt besteht. Prof. Dr. F.G. Bechara hat Vortragshonorare der Firma Abbvie erhalten.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Alle Patienten, die über Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Falle von nicht mündigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor.

Additional information

Aktualisierte Version der Originalpublikation in Der Hautarzt (2015) 66:413–422. doi:10.1007/s00105-015-3616-y

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kirschke, J., Hessam, S. & Bechara, F.G. Hidradenitis suppurativa/​Acne inversa. coloproctology 38, 159–168 (2016). https://doi.org/10.1007/s00053-015-0050-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00053-015-0050-7

Schlüsselwörter

Keywords

Search

Navigation